SCHEMBL20845017

SCHEMBL20845017

C1=C\c2ccc(-c3cc(-c4ccccc4)nc(-c4ccc(-c5cccnc5)cc4)n3)cc2-c2ccc3ccccc3c2Sc2ccccc2-c2ccccc2/1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 1/20 0.38
▸ ALDH1A1 P00352 5/20 0.35
▸ RAB9A P51151 4/20 0.35
▸ KDM4E B2RXH2 4/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ MAPT P10636 3/20 0.35
▸ HPGD P15428 3/20 0.35
▸ CYP19A1 P11511 2/20 0.34
▸ CYP11B1 P15538 2/20 0.34
▸ CYP17A1 P05093 1/20 0.34
▸ CYP11B2 P19099 1/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ TP53 P04637 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ USP1 O94782 6/20 0.33
▸ WDR48 Q8TAF3 6/20 0.33
▸ GAA P10253 2/20 0.33
▸ GLA P06280 2/20 0.33
▸ TSHR P16473 2/20 0.32
▸ S1PR1 P21453 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20845247 1.00 DHODH (0.38) DHODHALDH1A1RAB9AKDM4ESMN1; SMN2
SCHEMBL20845093 0.97 DHODH (0.38) DHODHALDH1A1RAB9AKDM4ESMN1; SMN2
SCHEMBL20845251 0.96 KDM4E (0.36) DHODHALDH1A1RAB9AKDM4ESMN1; SMN2
SCHEMBL20845018 0.96 ALDH1A1 (0.39) DHODHALDH1A1RAB9AKDM4ESMN1; SMN2
SCHEMBL20845087 0.95 DHODH (0.37) DHODHALDH1A1RAB9AKDM4ESMN1; SMN2
SCHEMBL20845249 0.94 RAB9A (0.37) DHODHALDH1A1RAB9AKDM4ESMN1; SMN2
SCHEMBL20845014 0.92 RAB9A (0.34) DHODHALDH1A1RAB9AKDM4ESMN1; SMN2
SCHEMBL20845250 0.92 ALDH1A1 (0.36) ALDH1A1KDM4ESMN1; SMN2MAPTHPGD
SCHEMBL20845011 0.92 ALDH1A1 (0.35) DHODHALDH1A1RAB9AKDM4ESMN1; SMN2
SCHEMBL20222579 0.91 DHODH (0.41) DHODHALDH1A1RAB9AKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190092745-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2019-03-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190092745-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME SCO2, AOX1, ORC3 DHODH 1763/4885ALDH1A1 981/4885RAB9A 635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback